Gunche 5 Million: Korean Zombie Film Passes 5 Million Admissions in 24 Days

Gunche crossed 5 million admissions in South Korea on the morning of June 13, 2026, reaching a reported cumulative total of 5,007,673 viewers. The milestone came on the film’s 24th day in theaters and made it the second 2026 release to pass 5 million admissions after The Man Who Lives with the King. ¹

The Gunche 5 Million mark was also confirmed through Showbox’s official YouTube community channel, which announced the film’s 5 million admissions milestone and noted that the film remained in theatrical release. ²

Gunche 5 Million Milestone Confirmed

The 5 million figure was reported against the Korean Film Council’s integrated cinema admissions data, with Dailian citing 5,007,673 cumulative admissions as of the morning of June 13. The same report placed the film at 4,965,838 cumulative admissions through the previous day, after drawing 54,066 viewers on June 12. ¹

Multiple reports described the result as a 24-day climb to 5 million admissions. MBC also reported that Gunche reached the threshold on June 13, its 24th day of release, and identified it as the second film released in 2026 to cross 5 million admissions after The Man Who Lives with the King. ³

Hankyoreh described Gunche as a zombie film directed by Yeon Sang-ho. MBC added that the film follows Yeon’s earlier zombie works Train to Busan and Peninsula, placing the new release within the director’s established genre filmography. ^{4 3}

Star Today summarized the film’s premise as a story set inside a sealed-off building during an unidentified infection outbreak, where survivors confront infected people who continue to evolve. ⁵

Pace of the Box-Office Run

Gunche built its total through a series of fast admissions thresholds. Hankyoreh reported that the film passed 1 million admissions on its fourth day, 2 million on its fifth day, 3 million on its 10th day, and 4 million on its 14th day before moving beyond 5 million on June 13. ⁴

Star Today reported that Gunche set the fastest 2026-release pace from 1 million through 5 million admissions. The outlet also reported that the film reached 5 million two days faster than Zombie Daughter, described in the source as the top-grossing Korean film of 2025. ⁵

The film’s performance did not stop at cumulative admissions. Hankook Ilbo reported that Gunche remained No. 1 at the box office in its fourth week of release, while also noting the 24-day timing of the 5 million milestone. ⁶

That fourth-week box-office status gives the milestone added context: Gunche was not only passing a headline admissions threshold, but doing so while still holding the top position in domestic theaters. The available reports do not provide a final total, and the cited figures reflect the June 13 morning status.

Cannes and Overseas Box-Office Context

Gunche had already drawn international attention before its domestic 5 million admissions mark. Hankook Ilbo reported that the film was officially invited to the Midnight Screening section of the 79th Cannes Film Festival and received a seven-minute standing ovation after its first local screening. ⁶

MBC also noted the Cannes Midnight Screening invitation, while describing the film as another zombie title from Yeon Sang-ho after Train to Busan and Peninsula. ³

The film’s regional box-office activity also extended beyond South Korea. Hankook Ilbo reported that after its domestic release, Gunche ranked No. 1 at the opening box office in major Asian markets including Malaysia, Taiwan, the Philippines, Singapore, and Hong Kong. ⁶

The 5 million milestone also drew a public response from the culture ministry. Hankyoreh reported that Minister of Culture, Sports and Tourism Choi Hwi-young posted a celebratory Facebook photo with Jun Ji-hyun, imitating an infected character from the film. His short caption read, “Finally releasing it.” ⁴

Gunche’s 5 million admissions milestone was reported across major Korean outlets and confirmed through Showbox’s official channel on June 13, 2026. Based on the available figures, the film reached the mark in 24 days, remained No. 1 in its fourth week, and became the second 2026 release to pass 5 million admissions after The Man Who Lives with the King.

작성자 소개

Cloi Lee

Author

모든 글 보기